Expansion of Pharmaceutical Firm in Philadelphia to Create Over 150 Jobs
09/07/2011
The move should be complete by fourth quarter 2012. Currently the firm takes up 19,000-sq.-ft. of space at the corporate facility.
Founded in 2006, Iroko specializes in nanoformulation technology used to to create improved versions of existing nonsteroidal, anti-inflammatory drugs.
Iroko President/CEO John Vavricka said his company needs the additional room to prepare for the anticipated launch of a new drug product, slated for 2013. "We've run out of space," he said. "Launching a product in the United States is going to require a much larger footprint."
Iroko was initially drawn to the location due to the numerous advantages Philadelphia offers life sciences businesses, such as its "highly educated workforce and research infrastructure," said a company official.
Project Announcements
Eos Energy Enterprises Expands Allegheny County, Pennsylvania, Operations
11/01/2025
Ahold Delhaize USA Plans Burlington, North Carolina, Distribution Operations
11/01/2025
Ulbrich Specialty Wire Products Expands Westminster, South Carolina, Production Operation
11/01/2025
Alcoa Expands Massena, New York, Operations
11/01/2025
SmartWiz Expands Birmingham, Alabama, Headquarters Operations
11/01/2025
Dutch-Based Maars North America Plans Mount Pleasant, South Carolina, Production Operations
11/01/2025
Most Read
-
2025’s Top States for Business: How the Winners Are Outpacing the Rest
Q3 2025
-
The Compliance Reckoning Is Here
Q3 2025
-
Around the Horn: Data Center Supply Chains — What's Next?
Q3 2025
-
How Consumer Trends Are Reshaping Food Facilities
Q3 2025
-
Powering the Next Generation of Projects
Q3 2025
-
First Person: Filter King’s Expansion Playbook
Q3 2025
-
Rethinking Auto Site Strategy in the Age of Tariffs and Powertrain Shifts
Q3 2025